KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Liabilities from Discontinued Operations (2023 - 2025)

Historic Liabilities from Discontinued Operations for Emergent BioSolutions (EBS) over the last 4 years, with Q3 2025 value amounting to $4.5 million.

  • Emergent BioSolutions' Liabilities from Discontinued Operations changed N/A to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year change of. This contributed to the annual value of $17.3 million for FY2015, which is N/A changed from last year.
  • Emergent BioSolutions' Liabilities from Discontinued Operations amounted to $4.5 million in Q3 2025.
  • In the past 5 years, Emergent BioSolutions' Liabilities from Discontinued Operations ranged from a high of $37.5 million in Q1 2023 and a low of $4.5 million during Q3 2025
  • In the last 3 years, Emergent BioSolutions' Liabilities from Discontinued Operations had a median value of $4.8 million in 2025 and averaged $12.3 million.
  • Examining YoY changes over the last 5 years, Emergent BioSolutions' Liabilities from Discontinued Operations showed a top increase of 5346.53% in 2025 and a maximum decrease of 5346.53% in 2025.
  • Emergent BioSolutions' Liabilities from Discontinued Operations (Quarter) stood at $37.5 million in 2023, then tumbled by 73.07% to $10.1 million in 2024, then crashed by 55.45% to $4.5 million in 2025.
  • Its last three reported values are $4.5 million in Q3 2025, $4.7 million for Q2 2025, and $4.8 million during Q1 2025.